Koers China Health Industries Holdings, Inc. Other OTC
Aandelen
CHHE
US1693981045
Farmaceutische producten
Omzet 2022 | 267 249,07 | Omzet 2023 | 112K 104K | Marktkapitalisatie | 14,66 mln. 13,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | -139.809 x |
Nettoliquiditeiten 2022 | 38,03 mln. 35,48 mln. | Nettoschuld 2023 | 5,11 mln. 4,76 mln. | EV/omzet 2023 | 177 x |
K/w-verhouding 2022 |
-1,98
x | K/w-verhouding 2023 |
-35,9
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 68,71% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Melody Zhang
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xin Sun
CEO | Chief Executive Officer | 58 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 699 mld. | |
+28,59% | 571 mld. | |
-3,55% | 364 mld. | |
+18,16% | 326 mld. | |
+4,36% | 286 mld. | |
+14,81% | 236 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 149 mld. |